Form 4 Tracker
Stephen Michael Kelsey

President, Research and Development · 3 filings · Latest: Jun 16, 2026

Revolution Medicines, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RVMD
Stephen Michael KelseyPresident, Research and DevelopmentJun 16, 2026
Sale
$156.124,175$651.8K291,876
RVMD
Kelsey Stephen MichaelJun 15, 2026
Proposed Sale
$153.874,071$626.4K
RVMD
Stephen Michael KelseyPresident, Research and DevelopmentMar 17, 2026
Sale
$99.484,302$428.0K295,398
RVMD
Kelsey Stephen MichaelMar 16, 2026
Proposed Sale
$99.593,901$388.5K
RVMD
Kelsey Stephen MichaelDec 15, 2025
Proposed Sale
$77.815,296$412.1K
RVMD
Kelsey Stephen MichaelSep 15, 2025
Proposed Sale
$46.555,296$246.5K
RVMD
STEPHEN M. KELSEYSep 11, 2025
Proposed Sale
$40.45150,000$6.1M
RVMD
Kelsey Stephen MichaelJun 16, 2025
Proposed Sale
$40.793,732$152.2K
RVMD
Kelsey Stephen MichaelMar 17, 2025
Proposed Sale
$38.893,611$140.4K
RVMD
Kelsey Stephen MichaelDec 16, 2024
Proposed Sale
$44.934,604$206.9K
RVMD
STEPHEN M. KELSEYNov 13, 2024
Proposed Sale
$59.3316,666$988.8K
RVMD
STEPHEN M. KELSEYOct 14, 2024
Proposed Sale
$50.4816,666$841.3K
RVMD
Kelsey Stephen MichaelSep 16, 2024
Proposed Sale
$42.124,601$193.8K
RVMD
STEPHEN M. KELSEYSep 13, 2024
Proposed Sale
$41.9716,667$699.5K